Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01578707 |
|---|---|
| Brief Title: | A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (RESONATE™) |
| First Submitted : | April 11, 2012 |
| First Submitted that Met QC Criteria : | April 13, 2012 |
| First Posted : | April 17, 2012 (Estimate) |
| Results First Submitted : | June 23, 2015 |
| Results First Submitted that Met QC Criteria : | September 11, 2015 |
| Results First Posted : | October 12, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 3, 2019 |
| Last Update Posted : | December 18, 2019 |